Schneider S C, Mitchison N A
German Rheumatology Research Center, Berlin.
J Immunol. 1995 Apr 15;154(8):3796-805.
Mechanisms of self-tolerance of 4-hydroxyphenylpyruvate dioxygenase (HPPD) are explored. It is well established that negative selection based on TCR affinity occurs in the thymus. We have investigated the frequency with which self-reactive T cell hybridomas can be obtained in relation to self-tolerance. Mice immunized with the self-form of HPPD gave rise to T cell hybridomas that were able to recognize self-protein and a synthetic peptide representing the T cell epitope, at higher Ag concentration than was necessary for recognition of allo-protein. The efficiency of negative selection was then reduced by treating neonatal mice with anti-HPPD antiserum. This reduced T cell tolerance of the self-protein, as judged by in vitro proliferation, and enabled self-reactive T cell hybridomas to be generated at a higher frequency. However, the Ag concentration requirements of these hybridomas for the self-protein and the self-peptide remained unaltered. The possibility that these findings reflect an auxiliary mechanism of self-tolerance based on frequencies of self-reactive T cells is discussed.
对4-羟基苯丙酮酸双加氧酶(HPPD)的自身耐受机制进行了探索。众所周知,基于TCR亲和力的阴性选择发生在胸腺中。我们研究了与自身耐受相关的可获得自身反应性T细胞杂交瘤的频率。用HPPD自身形式免疫的小鼠产生了能够识别自身蛋白和代表T细胞表位的合成肽的T细胞杂交瘤,其所需的抗原浓度高于识别同种异体蛋白所需的浓度。然后通过用抗HPPD抗血清处理新生小鼠来降低阴性选择的效率。根据体外增殖判断,这降低了对自身蛋白的T细胞耐受性,并使自身反应性T细胞杂交瘤能够以更高的频率产生。然而,这些杂交瘤对自身蛋白和自身肽的抗原浓度要求保持不变。讨论了这些发现反映基于自身反应性T细胞频率的自身耐受辅助机制的可能性。